Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: GEXVal Inc.
November 19, 2025
GEXVal Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of fragile X syndrome
Disease Area:
Rare Diseases
Source
Scroll to Top
